Holdings of the Fund as of 3/13/2026
Total Number of Holdings (excluding cash): 19
| US Dollar |
$USD |
|
28,576,468 |
$28,576,468.10 |
72.75% |
| Electronic Arts Inc. |
EA |
285512109 |
8,745 |
$1,742,353.80 |
4.44% |
| Confluent, Inc. (Class A) |
CFLT |
20717M103 |
52,244 |
$1,602,323.48 |
4.08% |
| CSG Systems International, Inc. |
CSGS |
126349109 |
19,075 |
$1,524,283.25 |
3.88% |
| Brighthouse Financial, Inc. |
BHF |
10922N103 |
24,037 |
$1,447,748.51 |
3.69% |
| Hologic, Inc. |
HOLX |
436440101 |
18,400 |
$1,382,208.00 |
3.52% |
| Exact Sciences Corporation |
EXAS |
30063P105 |
11,644 |
$1,205,969.08 |
3.07% |
| Air Lease Corporation |
AL |
00912X302 |
18,501 |
$1,193,684.52 |
3.04% |
| ProAssurance Corporation |
PRA |
74267C106 |
24,512 |
$603,730.56 |
1.54% |
| Bristol-Myers Squibb Co. - CVR |
2367655D |
|
39,856 |
$0.00 |
0.00% |
| California Resources Corporation |
CRC |
13057Q305 |
1 |
$61.47 |
0.00% |
| Chinook Therapeutics Cvr |
.KDNYCVR |
169CVR016 |
43,869 |
$0.00 |
0.00% |
| Huntington Bancshares Incorporated |
HBAN |
446150104 |
-3 |
($45.63) |
0.00% |
| Icosavax Inc Cvr |
.ICVXCVR |
451CVR021 |
100,745 |
$0.00 |
0.00% |
| Johnson & Johnson - CVR |
.JNJ-CVR |
003CVR016 |
7,137 |
$0.00 |
0.00% |
| Nicolet Bankshares, Inc. |
NIC |
65406E102 |
1 |
$149.21 |
0.00% |
| Pfizer Inc (CVR) |
2596459D |
|
20,075 |
$0.00 |
0.00% |
| Roche Holding AG - CVR |
2595777D.SW |
|
69,580 |
$0.00 |
0.00% |
| Sycamore Partners Llc -Right |
2556706D |
931CVR013 |
76,307 |
$0.00 |
0.00% |
| Zimmer Biomet Holdings, Inc. (CVR) |
2544621D |
|
97,345 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|